$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Latest Closing Price
$42.15Market Cap
$5.23 BillionPrice-Earnings Ratio
15.50Total Outstanding Shares
124.90 Million SharesTotal Employees
5,700Dividend
$0.58 Per Share QuarterlyIPO Date
May 29, 1986SIC Description
Chemicals & Allied ProductsPrimary Exchange
New York Stock ExchangeHeadquarters
2929 Walnut Street, Philadelphia, PA, 19104| Execution Date | Split Amount |
|---|---|
| May 25, 2012 | 2-for-1 |
| September 14, 2007 | 2-for-1 |
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Discontinued | $-65.60 Million |
| Net Cash Flow From Operating Activities, Continuing | $736.70 Million |
| Net Cash Flow From Financing Activities | $-870.10 Million |
| Net Cash Flow, Discontinued | $-65.60 Million |
| Net Cash Flow | $64.60 Million |
| Net Cash Flow From Investing Activities, Continuing | $263.60 Million |
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $-150.90 Million |
| Operating Expenses | $1.14 Billion |
| Diluted Earnings Per Share | $2.72 |
| Income/Loss From Continuing Operations After Tax | $403.40 Million |
| Diluted Average Shares | $125.36 Million |
| Cost Of Revenue | $2.60 Billion |
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $336.50 Million |
| Other Comprehensive Income/Loss | $-5.10 Million |
| Comprehensive Income/Loss Attributable To Parent | $337 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $-500,000 |
| Metric | Value |
|---|---|
| Liabilities | $7.14 Billion |
| Intangible Assets | $2.36 Billion |
| Other Current Assets | $853.50 Million |
| Noncurrent Liabilities | $4.13 Billion |
| Fixed Assets | $849.70 Million |
| Inventory | $1.20 Billion |
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 28, 2025 | Apr 17, 2025 | Mar 31, 2025 | $0.58 | Quarterly |
| Dec 13, 2024 | Jan 16, 2025 | Dec 31, 2024 | $0.58 | Quarterly |
| Jul 19, 2024 | Oct 17, 2024 | Sep 30, 2024 | $0.58 | Quarterly |
| Apr 30, 2024 | Jul 18, 2024 | Jun 28, 2024 | $0.58 | Quarterly |
| Feb 27, 2024 | Apr 18, 2024 | Mar 28, 2024 | $0.58 | Quarterly |
| Dec 15, 2023 | Jan 18, 2024 | Dec 29, 2023 | $0.58 | Quarterly |